LENSAR Inc
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
LNSR$5.46+0.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber | Description | Form | File No. | Exhibit | Filing Date | Filed/FurnishedHerewith |
|---|---|---|---|---|---|---|
| 2.1+ | Separation and Distribution Agreement between PDL BioPharma, Inc. and LENSAR, Inc. | Form 8-K | 001-39473 | 2.1 | 10/2/2020 | |
| 2.2+ | Agreement and Plan of Merger, dated as of March 23, 2025, by and among LENSAR, Inc., Alcon Research, LLC, and VMI Option Merger Sub, Inc. | Form 8-K | 001-39473 | 2.1 | 3/24/2025 | |
| 3.1 | Amended and Restated Certificate of Incorporation of LENSAR, Inc. | Form 8-K | 001-39473 | 3.1 | 10/2/2020 | |
| 3.2 | Amended and Restated Bylaws of LENSAR, Inc. | Form 10-Q | 001-39473 | 3.2 | 11/07/2024 | |
| 3.3 | Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock filed May 18, 2023 | Form 8-K | 001-39473 | 3.1 | 5/18/2023 | |
| 4.1 | Form of Certificate of Common Stock | Form 10/A | 001-39473 | 4.1 | 9/14/2020 | |
| 4.2 | Registration Rights Agreement, dated May 12, 2023, between LENSAR, Inc, and NR-GRI Partners, LP | Form 8-K | 001-39473 | 10.2 | 5/15/2023 | |
| 4.3 | Class A Common Stock Purchase Warrant, dated May 18, 2023 | Form 8-K | 001-39473 | 4.1 | 5/18/2023 | |
| 4.4 | Class B Common Stock Purchase Warrant, dated May 18, 2023 | Form 8-K | 001-39473 | 4.2 | 5/18/2023 | |
| 31.1 | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended | * | ||||
| 31.2 | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended | * | ||||
| 32.1 | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ** | ||||
| 32.2 | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ** | ||||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document | * | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | * | ||||
| 104 | Cover Page Interactive Data File (as formatted as Inline XBRL and contained in Exhibit 101) | * | ||||
- Certain schedules and attachments to certain of these exhibits have been omitted pursuant to Regulation S-K, Item 601(a)(5). The Company hereby undertakes to furnish supplemental copies of any of the omitted exhibits and schedules upon request by the SEC; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any exhibits or schedules so furnished.
- Filed herewith.
** Furnished herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.